Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pennington

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Annals of Surgical Oncology|March 30, 2002
The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsySandra L Wong, Michael J Edwards, Celia Chao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2024
Clinical significance of intra-thoracic and intra-abdominal sentinel lymph nodes detected on lymphoscintigraphy in truncal melanoma patientsElan Novis, Ahmad Sulaiman, Jonathan Stretch, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2022
Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomesMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
Annals of Surgical Oncology|May 27, 2024
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 MelanomasAlec A Winder, Zoe Boyer, Sydney Ch'ng, et al.
Annals of Surgery|August 29, 2001
Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniquesK M McMasters, S L Wong, C Chao, et al.
Nature Medicine|June 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF<sup>V600</sup>-mutant resectable melanoma: the randomized phase 2 NeoTrio trialGeorgina V Long, Matteo S Carlino, George Au-Yeung, et al.
Annals of Surgery|May 22, 2001
Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional studyK M McMasters, S L Wong, R C Martin, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Annals of Surgical Oncology|March 30, 2002
The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsySandra L Wong, Michael J Edwards, Celia Chao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2024
Clinical significance of intra-thoracic and intra-abdominal sentinel lymph nodes detected on lymphoscintigraphy in truncal melanoma patientsElan Novis, Ahmad Sulaiman, Jonathan Stretch, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2022
Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomesMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
Annals of Surgical Oncology|May 27, 2024
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 MelanomasAlec A Winder, Zoe Boyer, Sydney Ch'ng, et al.
Annals of Surgery|August 29, 2001
Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniquesK M McMasters, S L Wong, C Chao, et al.
Nature Medicine|June 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF<sup>V600</sup>-mutant resectable melanoma: the randomized phase 2 NeoTrio trialGeorgina V Long, Matteo S Carlino, George Au-Yeung, et al.
Annals of Surgery|May 22, 2001
Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional studyK M McMasters, S L Wong, R C Martin, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Pageof 24